ISB 2017

Xsens will be exhibiting at the XXVI Congress of the International Society of Biomechanics 2017. We will demonstrate the MVN BIOMECH and MTw Awinda products.

ISB will take place July 23-27, 2017 in Brisbane, Australia. Visit us at booth #21.

If you would like to make an appointment at ISB, feel free to contact us at [email protected].


When: Wednesday July 26th : 5pm – 6pm
Where: P5 

Xsens will host an exclusive session at ISB to show and demonstrate a new method for inertial motion capture and will demonstrate this with consistent and magnetically immune kinematic data.
We want to give you the opportunity to evaluate the recorded data yourself by sharing the data after the session. Sign up during the session to receive this data.

Session Content:

1. New method for inertial motion capture proving consistent and magnetically immune kinematic data
Recently, Xsens has developed a method for inertial motion capture that does not suffer from sensitivity to magnetic distortions and provides a reliable and consistent estimate of subject kinematics anywhere irrespective of the magnetic environment. Xsens will present an in-depth presentation including an exclusive preview of this new method.

2. Net knee moment estimation using exclusively inertial measurement units
Presentation by Angelos Karatsidis, researcher at Xsens and PhD student at the Biomedical Signals & Systems group at the University of Twente. Currently working on the KNEEMO project.

3. Innovative applications using Xsens inertial motion capture
Xsens customers will present how they are using Xsens technology for the biomechanics research and applications.

About ISB

ISB 2017 is expected to attract over 1,200 delegates from around the world, representing a variety of disciplines in biomechanics including anatomy, physiology, engineering, orthopaedics, rehabilitation medicine, sports science and medicine, ergonomics, electrophysiological kinesiology and others.
ISB website



Xsens newsletter

Signup today to stay updated on all major Xsens news and developments. Subscribe now